Online resource for AMD

Article

Ocular nutraceutical company, EyeScience Labs, LLC, has launched www.EyeScience.com that aims to meet the need for comprehensive information and education on age-related macular degeneration (AMD) in a watch-and-learn video format.

Ocular nutraceutical company, EyeScience Labs, LLC, has launched www.eyescience.com that aims to meet the need for comprehensive information and education on age-related macular degeneration (AMD) in a watch-and-learn video format.

The site contains basic eye anatomy, screening and diagnosis, risk factors, signs and symptoms and treatments for AMD. There are also more than 20 watch-and-learn videos about eye anatomy, AMD symptoms, dry and wet macular degeneration, diagnostic tests, photodynamic therapy (PDT), intravitreal injection of Lucentis and Avastin, vitamin therapy, amsler grid testing, lasers and more.

Users also have the ability to browse an FAQ section, which contains expert answers to more than 30 questions about AMD. An additional feature is an 'Ask the Doctor' section where browsers can submit their questions about AMD or problems they may personally be experiencing with their eyes and EyeScience medical experts will answer them privately and free-of-charge.

Visit the site at www.eyescience.com and let us know what you think at www.oteurope.com/discuss

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.